)
Edge17 Oct 2025
A Castle in the Sky: The Story of Oracle
Oracle's journey from database innovator to disciplined enterprise backbone, now shaping the AI buildout with a standardized cloud infrastructure.
G1 Therapeutics (GTHX) investor relations material
G1 Therapeutics Q2 2024 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2024 earnings summary8 Aug, 2024
Executive summary
Net product sales for COSELA increased 43% year-over-year to $15.8 million for Q2 2024, with double-digit quarter-over-quarter growth in vial volume and net revenue.
License revenue dropped to $0.7 million from $31.3 million in Q2 2023, reflecting the absence of prior year one-time payments.
Net loss for Q2 2024 was $5.5 million, compared to net income of $8.7 million in Q2 2023, due to lower license revenue.
Pending acquisition by Pharmacosmos for $7.15 per share in cash, expected to close in late Q3 2024.
Announced two license agreements for lerociclib, providing upfront payments, milestones, and royalties.
Financial highlights
Q2 2024 revenues: $16.5 million (product sales $15.8M, license revenue $0.7M); Q2 2023: $42.4 million (product sales $11.1M, license revenue $31.3M).
Operating expenses decreased to $20.1 million in Q2 2024 from $30.9 million in Q2 2023, mainly from lower R&D and SG&A costs.
Net loss per share was $(0.10) (basic and diluted) for Q2 2024, versus $0.17 (basic) and $0.14 (diluted) in Q2 2023.
Cash, cash equivalents, and marketable securities totaled $60.7 million as of June 30, 2024.
Accumulated deficit reached $795.7 million as of June 30, 2024.
Outlook and guidance
Reaffirmed 2024 net COSELA revenue guidance of $60M–$70M.
Expects 2024 operational expenses to be 25%–30% below 2023 levels.
Management expects to achieve profitability in the second half of the next fiscal year.
Cash runway expected to fund operations into Q3 2025 and cover covenants for at least 12 months.
No new R&D activities planned; focus remains on global commercialization of COSELA.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Company Research17 Oct 2025
Beneath the Surface: A Conversation with Epiroc CEO Helena Hedblom
Legacy, innovation, and leading one of Sweden's most influential industrial companies into a new era.
)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Frequently asked questions
G1 Therapeutics Inc is a biopharmaceutical company developing therapies for the treatment of cancer. The company focuses on small-molecule drugs designed to preserve bone marrow and enhance the effectiveness of chemotherapy. Its operations span research, clinical development, and regulatory affairs. The company is headquartered in Research Triangle Park, North Carolina, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage